Avalon Ventures Backs Averon

socalTECH

La Jolla-based Avalon Ventures is the lead investor in the Series A round for Averon , a developer of mobile identity verification software this week. Avalon's Rich Levandov and Brady Borhmann both join Averon's board with the funding round. capital venture smartphone software identity mobile averon ventures avalonAveron, which is based in San Francisco, said it has raised $8.3M in a Series A funding.

Avalon 100

Avalon Ventures Backs Teambox

socalTECH

San Diego-based venture investor Avalon Ventures is the lead investor in a round for a developer of cloud-based, business collaboration software today. According to Teambox , which was founded in Barcelona, Spain, and which is setting up headquarters in Redwood City, it raised $5M in a Series A led by Avalon Ventures, and which also included the Data Collective Fund. Avalon''s Rich Levandov was involved in the funding effort.

Avalon 131

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avalon Ventures Gets Exit At Sitari Pharmaceuticals

socalTECH

San Diego-based biotech investor Avalon Ventures has scored an exit, saying late Tuesday evening that it has entered into a definitive agreement with GlaxoSmithKline (GSK), to sell Sitari Pharmaceuticals to GSK. According to Avalon Ventures, Sitari was the very first company to be formed under the GSK-Avalon venture collaboration, in 2013. who also serves as President and CEO of COI and is a Managing Director at Avalon Ventures.

Avalon 100

Avalon Ventures Leads Round In AeroFS

socalTECH

San Diego-based venture investor Avalon Ventures is the lead investor in a new, $10M funding round for AeroFS , a developer of private cloud collaboration software. Avalon's Rich Levandov represents Avalon Ventures on the AeroFS board. aerofs venture capital private cloud collaboration software saas avalon ventures rich levandov

Avalon 135

Avalon Ventures Backs Pingup

socalTECH

Avalon Ventures , the La Jolla- and Cambridge-based venture capital firm, has backed a new startup, Pingup , which lets consumers text nightclubs for reservations and information. According to Pingup Tuesday, it raised $1M in a seed funding round from Avalon Ventures, led by Brady Bohrmann. nightlife restaurant mobile nightclub message text capital venture ventures avalon pingup

Avalon 130

Avalon Ventures Backs TwinStrata

socalTECH

La Jolla-based venture capital investor Avalon Ventures is the lead in a round for cloud data storage firm TwinStrata , TwinStrata said today. TwinStrata, which is based in Masachusetts, said that Avalon lead its Series B funding round, which was worth $8M. Avalon's investment in TwinStrata was headed by Rich Levandov. Avalon also has offices in Massachusetts. twinstrata data gateway cloud storage hardware venture capital avalon ventures

Avalon 126

Avalon Ventures Spins Out New Company, Iron Horse Therapeutics

socalTECH

San Diego-based venture investor Avalon Ventures , along with biopharmaceuticals firm GSK said this morning that the two companies are spinning out a new company, Iron Horse Therapeutics , backed by $10M in funding. The companies said that Iron Horse will also receive R&D support from Avalon and GSK (GlaxoSmithKline), as well as R&D and mentoring support from COI Pharmaceuticals.

Avalon 132

Avalon Ventures Backs Selectable Media

socalTECH

San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. The funding round actually closed on September 5th, according to regulatory details released last month, and Selectable Media has been listed on Avalon's site since last month; more details on the funding were reported today. selectable media venture capital video advertising avalon

Avalon 131

Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck

Xconomy

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Calporta, like the other companies launched from the Avalon-GSK (NYSE: GSK ) deal, has been incubating at COI Pharmaceuticals, a shared space in La Jolla, CA, created by Avalon for its portfolio companies.

Avalon Ventures Launches Trio Of Life Science Startups

socalTECH

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK. Avalon and GSK have a deal to fund and launch up to 10, early-stage life sciences companies together.

Avalon 138

Avalon Ventures Backs Indix For E-Commerce Product Data

socalTECH

San Diego-based venture investor Avalon Ventures has re-upped its investment in product database provider Indix , as part of a $15M Series B funding. The funding round came from Nokia Growth Partners, Nexus Venture Partners and Avalon Ventures. Avalon was one of the lead investors in the last funding round for Indix, which is based Seattle and San Francisco. indix product information database venture capital ecommerce catalog avalon ventures

Avalon 132

Avalon Ventures Gets Commitments Of $103M In New, $300M Fund

socalTECH

La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. diego lifescience technology funding fund investment capital venture ventures avalon

Avalon 135

Avalon Ventures Closes $200M Fund

socalTECH

San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company. Avalon is headed by Kevin Kinsella, Stephen Tomlin, Jay Lichter, Doug Down, Rich Levandov and Brady Borhmann.

Avalon 126

Avalon Ventures Raises $201.6M As Part Of $250M Venture Fund

socalTECH

In what is a rarity nowadays for a Southern California venture capital fund, San Diego- and Cambridge-based venture capital firm Avalon Ventures has just closed on $201.6M in commitments for a $250M fund, Avalon Ventures X. Avalon has backed such companies as Zynga, Ambit Biosciences, AnayptsBio, Awarepoint, Cheezburger, Inogen, MOGL, Ortiva Wireless, and others. The new fund comes only about two years after Avalon's last fund, Avalon Ventures IX, a $200M fund, was announced.

Avalon 156

Avalon Ventures Gets Exit At Cloudant

socalTECH

San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. Cloudant had been backed by Avalon Ventures, Devonshire Investors, In-Q-Tel, Rackspace, Samsung, and Toba Capital, and had only raised around $14.0M

Avalon 148

Avalon Leads Investment In Standing Cloud

socalTECH

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group. Avalon's Rich Levandov joins Standing Cloud's board as part of the funding. application computing standingcloud cloud standing ventures avalon

Avalon 136

Avalon Funds Internet Comedy Site Cheezburger

socalTECH

San Diego-based venture capital firm Avalon Ventures has boosted an Internet web site publisher known for its humorous, captioned pictures of cats and use of Internet memes, Cheezburger. According to Cheezburger, Avalon was one of a number of venture firms investing in the company's $30M funding today, and has added Avalon partner Rich Levandov to its board of directors. humor comedy publishing content capital network cheezburger venture avalon

Avalon 140

Avalon Ventures Backs Averon For Mobile Identity Verification

socalTECH

La Jolla-based venture investor Avalon Ventures is the lead investor in a round for San Francisco-based Averon , a developer of mobile identity verification software. The funding was led by Avalon Ventures, and also included Salesforce founder and CEO Marc Benioff. Avalon Ventures' investment was managed by Brady Bohrmann.

Avalon 100

Avalon Ventures: Startups Get Milestone Payments, New Company Launched With GSK

socalTECH

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration. That company is apparently the eigth company formed by Avalon and GSK.

Avalon 109

Avalon Ventures, GlaxoSmithKline Team On Two New Startups

socalTECH

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. Both of those new drug discovery startups will be located in San Diego, at COI Pharmaceuticals, the biotech research facility recently established by Avalon Ventures. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.

Avalon 100

Avalon Ventures Might Reap Cash In Zynga Offering

socalTECH

San Diego-based Avalon Ventures , one of the venture capital investors in social gaming phenomenon Zynga , may be set to cash in on its shares of the newly public gaming firm, after Zynga said this week that it is planning a $400M, secondary offering of its stock. Zynga's major backers are Kleiner Perkins Caufield & Byers, IVP, Union Square Ventures, Foundry Ventures, and Avalon Ventures. avalon ventures zynga content merger acquisition videogame social

Avalon 133

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. [ Note: The headline has been corrected to better describe the company’s type of funding. 9/27/16, 2:09 p.m.

Avalon Ventures, Jeffrey Katzenberg To Benefit From Zynga IPO

socalTECH

Among the investors who may benefit from a successful IPO are La Jolla-based Avalon Ventures , run by Kevin Kinsella, Stephen Tomlin, Richard Levandov, Brady Bohrmann, Doug Downs and Jay Lichter, which before the IPO owned 6.1 dreamworks katzenberg capital venture avalon exit content videogame games social acquisition merger zynga

Avalon 126

Nerio Therapeutics Finds $3.0M

socalTECH

The company appears to be another company emerging from COI Pharmaceutiacls , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, as Sanford Madigan, Jay Lichter, and Tighe Reardon are all listed as officers of the new company. pharmaceuticals nereo therapeutics stanford neurobiology avalon ventures venture capital biotech lifescience

Xencor Names New Board Member

socalTECH

Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. xencor biotechnology oncology kevin gorman avalon neurocrine biosciences boardMonrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., to its board of directors.

Fortis Therapeutics Raises $18M

socalTECH

The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. avalon metastatic cancer drug oncology lifescience biotech capital venture therapeutics fortisSan Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding.

Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown

Xconomy

The coronavirus pandemic is narrowing the avenues open to biotechs for financing their endeavors, according to some industry veterans. “I

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

Xconomy

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease. Sitari was the first of eight companies spun up through the partnership between the Southern California investment outfit and British pharma company.

Clearstone Tops CalPERS IRR List

socalTECH

Second on the returns list was Avalon Ventures VIII, L.P. investment calpers ventures capital venture avalon clearstoneCalPERS (the California Public Employees' Retirement System), one of the biggest limited partners in venture capital funds, has released its best and worst performing venture capital and private equity funds as of December 31st, showing that two Southern California venture funds were tops in terms of internal rates of return (IRR).

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

Xconomy

Synthetic biology company Synthorx is laying plans for an initial public offering to raise money to advance its suite of enhanced cytokine drugs.

Synthorx Gets $131M In Upsized IPO For Synthetic Biology Drugs

Xconomy

Synthorx, which is working to develop cancer and autoimmune therapies using technology that allows it to expand the genetic alphabet, raised $131 million in an upsized IPO on Thursday. The company sold more than 11.9 million shares at $11 apiece. Nearly 1.8 million additional shares are available for its underwriters to purchase. Synthorx, headed by president and CEO Laura Shawver, had planned to sell 9.1 million shares for between $10 and $12 each.

Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data

Xconomy

Boston blog main National blog main San Diego San Diego blog main San Diego top stories Acquisition Adam Simpson Amgen Asit Parikh Avalon Biotech celiac Clinical Trial COI Cour Pharmaceuticals Drug Development Financing Frazier Healthcare Partners GlaxoSmithKline gluten licensing Life Sciences M&A Meritage Pharma Provention Bio PVP Biologics Sitari Pharmaceuticals Tachi Yamada Takeda

Study 52

Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More

Xconomy

For decades, advanced lung cancer was a quick death sentence. That’s no longer a given, thanks in part to the arrival of immunotherapy. If a medical meeting in Barcelona this week was any indication, more help could be on the way. Targeted medicine isn’t new to lung cancer, but only a fraction of patients have the eligible mutations, such as EGFR and ALK, and thus have a chance to avoid chemotherapy and its toxic side effects.

aFraxis Gets $750K

socalTECH

Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures. Avalon's Jay Lichter is listed as the firm's CEO. Tags: afraxis venture capital biotech lifescience autism avalon ventures San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday.

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

Xconomy

National blog main National top stories San Diego San Diego blog main San Diego top stories San Francisco blog main Avalon Ventures Biotech cancer Cetus Chiron Correlation Ventures deals Drugs Entrepreneurship Financing Floyd Romesberg funding IL-2 Immuno-oncology innovation Interleukin-2 Laura Shawver Life Sciences Medicxi Orbimed Osage University Partners people RA Capital Management startups Synthetic Biology Synthorx VC Venture Capital

No Vital Signs Apparent at Wireless Health Specialist Awarepoint

Xconomy

National blog main National top stories San Diego San Diego blog main San Diego top stories Avalon Ventures Awarepoint Devices Digital Health enrock Hardware healthcare Healthtech Heritage Healthcare Innovation Fund Icon Ventures innovation IT Kleiner Perkins Caufield & Byers Life Sciences New Leaf Venture Partners Radio Frequency Identification Devices (RFID) Software Top Tier Capital Partners wireless Wireless Health ZigBee

Tips 65

AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut

Xconomy

National blog main San Diego San Diego blog main San Diego top stories AnaptysBio antibody drug Avalon Ventures Biotech biotech IPO cancer immunotherapy Celgene clinical trials FDA Food and Drug Administration Frazier Healthcare Life Sciences Novo A/S ObsEva rare disease drugs Renaissance Capital TesaroAnaptysBio is the first U.S. biotech company to go public this year, raising $75 million in an IPO intended to finance development of antibody-based drugs for inflammatory disorders.

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy

and San Diego’s Avalon Ventures. Avalon Ventures founded Avelas, and has housed the startup with other Avalon biotech startups at its COI Pharmaceuticals R&D facility in San Diego. Avalon Ventures founder Kevin Kinsella plans to step down as a director of the company, along with Nikolay Savchuk of Torrey Pines Investment. Avalon partner Jay Lichter plans to continue serving as Avelas’ chairman, Stengone said.

Study 62

Intel Deepens Move into Sports Tech with SportStream Investment

Xconomy

According to a recent ScoreStream statement , San Diego’s Avalon Ventures, a longtime ScoreStream investor, led the round, and was joined by Sinclair Broadcasting, Verizon Ventures, and R/GA Ventures, the investment arm of the advertising agency R/GA. ScoreStream, a five-year-old startup that created a social media platform for crowd-sourcing local sports scores, has raised $3.7 million in a Series A round that includes Intel Capital as an investor.

Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed

Xconomy

Boston blog main Boston top stories National blog main San Diego San Diego blog main San Diego top stories Avalon Ventures Ciprofloxacin clinical trials David Weber dexamethasone Drugs FDA Hearing Loss Jay Lichter Life Sciences Meniere's Disease Otiprio OtonomyInvestment in experimental drugs for hearing loss, long an untapped field in the pharmaceutical industry, may be picking up, but drugs that actually help with these disorders remain elusive.

Smarr, Others Talk Healthtech, AI at Xconomy’s Impact of Innovation

Xconomy

View the Slideshow In the not-too-distant future, a “planetary” computer will be able to create a computational model of your body, with the ability to run simulations of your health and to anticipate chronic disease before you show any symptoms. This is the direction we’re headed, according to Larry Smarr, founding director of the California Institute of Telecommunications & Information Technology at UC San Diego.

Today Only: Save $70 for Human Impact of Innovation on April 19th

Xconomy

National National blog main San Diego San Diego blog main San Diego top stories Amir Khosrowshahi Avalon Ventures Partner Clayton Lewis Cybersecurity Dan Goldin Henrik Christensen Illumina Jay Lichter Jeff Hawkins Larry Smarr Life Sciences Nakul Duggal nasa Precision Medicine Qualcomm Scripps Translational Science Institute Self-Driving Vehicles startups Steven Steinhubl VC

Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More

Xconomy

Avalon Ventures led an $18 million Series A round for new cancer immunotherapy startup Fortis Therapeutics. The presidential race captivated millions of TV viewers this week as the first debate took place in Hofstra. But biotech watchers had other races on their mind. Who will be first to market with a new type of cancer treatment known as CAR-T? Who will break free of the pack of companies developing drugs meant to prevent migraines?